Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

DuPont presents new series of HIV reverse transcriptase inhibitors

April 30, 1999

Vitravene recommended for European approval as CMV retinitis therapy

April 30, 1999

Japanese marketing approval granted for AIDS wasting treatment

April 28, 1999

Vertex and Glaxo Wellcome begin shipping new anti-HIV compound

April 27, 1999

Coumarin derivatives with antiviral activity against HIV from Pliva

April 26, 1999

Novel antiviral agent active against HIV-1 and other viruses developed in Russia

April 26, 1999

Metabolism and disposition of novel anti-HIV agent studied in isolated rat liver

April 23, 1999

Eisai research team discovers novel HIV-1 Tat antagonist

April 20, 1999

New, second-generation HIV fusion inhibitor from Trimeris to be evaluated clinically

April 20, 1999

FDA approves amprenavir, first new protease inhibitor in more than two years

April 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
In the clinic for July 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 4D, Actinogen, Belite, Harrow, Nuvation, Prolocor, Regenxbio, Samsung Bioepis.
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...